Cargando…
Targeting Staphylococcal Cell–Wall Biosynthesis Protein FemX Through Steered Molecular Dynamics and Drug-Repurposing Approach
[Image: see text] Staphylococcus aureus-mediated infection is a serious threat in this antimicrobial-resistant world. S. aureus has become a “superbug” by challenging conventional as well as modern treatment strategies. Nowadays, drug repurposing has become a new trend for the discovery of new drug...
Autores principales: | Rahman, Shakilur, Nath, Subham, Mohan, Utpal, Das, Amit Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433341/ https://www.ncbi.nlm.nih.gov/pubmed/37599983 http://dx.doi.org/10.1021/acsomega.3c02691 |
Ejemplares similares
-
Aminoacyl-tRNA recognition by the FemX(Wv) transferase for bacterial cell wall synthesis
por: Fonvielle, Matthieu, et al.
Publicado: (2009) -
Integrated Multi-omics, Virtual Screening and Molecular Docking Analysis of Methicillin-Resistant Staphylococcus aureus USA300 for the Identification of Potential Therapeutic Targets: An In-Silico Approach
por: Rahman, Shakilur, et al.
Publicado: (2021) -
Repurposing ebselen for treatment of multidrug-resistant staphylococcal infections
por: Thangamani, Shankar, et al.
Publicado: (2015) -
Living with an imperfect cell wall: compensation of femAB inactivation in Staphylococcus aureus
por: Hübscher, Judith, et al.
Publicado: (2007) -
Repurposing the PDMA-approved drugs in Japan using an insect model of staphylococcal infection
por: Miyashita, Atsushi, et al.
Publicado: (2022)